The Appearance Anxiety Inventory (AAI) is a validated, 10-item self-report scale that measures the cognitive processes and safety behaviors, such as rumination, self-focused attention, avoidance, and checking, that characterize body dysmorphic disorder (BDD). Clinicians use it to gauge appearance-related anxiety and to track how it changes over a course of treatment.
Developed by Veale and colleagues in 2014, the AAI was designed as a process measure: a way to monitor the mechanisms that maintain BDD rather than to diagnose it. It is widely used in mental health settings and is increasingly relevant in dermatology and aesthetic practices, where appearance concerns frequently present.
Why healthcare providers use the AAI
- Fast, structured insight. Ten items give a standardized read on how much appearance concerns are driving avoidance and checking, without a lengthy interview.
- Tracking change over time. As a process measure, the AAI is well suited to repeated administration, so scores across sessions show whether treatment is helping.
- A shared language. A single number gives the patient and care team a common reference point for discussing progress.
- Surfacing hidden concerns. In cosmetic and dermatology settings, it can flag patients whose distress may not be resolved by a procedure.
Which settings use the AAI?
- Psychiatry and psychology. The primary setting, used during assessment and throughout treatment for BDD.
- Dermatology. Patients with BDD often seek dermatologic care; the AAI helps distinguish appearance anxiety from a treatable skin condition.
- Aesthetic and cosmetic practices. Body dysmorphic concerns are common among people seeking cosmetic procedures.
- Telehealth. As a short self-report scale, it is easy to complete before a virtual visit.
What does the AAI measure?
The AAI's 10 items capture two related patterns seen in body dysmorphic disorder:
- Threat monitoring and cognitive preoccupation, such as rumination about perceived flaws, self-focused attention, and comparing one's appearance to others.
- Avoidance and safety behaviors, such as avoiding situations or mirrors and checking or camouflaging perceived defects.
Research on the scale has described a two-factor structure reflecting avoidance and threat monitoring. Because the AAI is freely available for use with citation, practices can adopt it without a license, provided the source is credited.
Scoring the AAI
- Number of items: 10
- Per-item response scale: 0 (not at all) to 4 (all the time)
- Total score range: 0 to 40
- Score direction: higher scores indicate greater appearance-related anxiety
- Primary purpose: monitoring change during treatment
The AAI is a process and severity measure rather than a diagnostic test. In the validation research, a score of 19 or above indicated clinically significant appearance anxiety, while a score of 13 or below reflected full or partial remission, and a reduction of 40 percent or more signaled a treatment response. Any single score should be interpreted by a qualified clinician within the full clinical picture.
The table below summarizes how AAI scores are commonly interpreted, using thresholds reported in the validation research. It is a guide to support clinical judgment, not a diagnostic rule.
| AAI score | Interpretation | Suggested next step |
|---|---|---|
| 0-13 | Low appearance anxiety, within the remission range | Monitor |
| 14-18 | Sub-threshold appearance anxiety | Watchful waiting |
| 19-40 | Clinically significant appearance anxiety, consistent with BDD | Consider full BDD assessment |
Best practices for administration
- Administer at intake to establish a baseline, then re-administer at regular intervals to track change.
- Keep the wording and 0 to 4 response format intact; the scale is validated as written.
- Review elevated or rising scores in the context of a full assessment rather than in isolation.
- Because BDD carries an elevated risk of suicidal ideation, pair appearance-focused screening with appropriate risk assessment when clinically indicated.
- Document scores consistently so progress is visible across the plan of care.
- Cite the scale (Veale et al., 2014) when using or reporting it.
How Zentake helps with the AAI
- Automatic scoring. Zentake totals the AAI the moment a patient submits, so staff never tally by hand.
- Longitudinal tracking. Re-send the AAI on a schedule and view scores over time.
- Risk flagging. Concerning responses can be surfaced to staff for timely follow-up.
- Before the visit. Patients complete the AAI from home on any device, so the clinician starts the session already informed. Built for mental health practices.
- HIPAA compliant. Sensitive responses stay encrypted, with a signed BAA on every plan.
References
Veale, D., Eshkevari, E., Kanakam, N., Ellison, N., Costa, A., & Werner, T. (2014). The Appearance Anxiety Inventory: Validation of a process measure in the treatment of body dysmorphic disorder. Behavioural and Cognitive Psychotherapy, 42(5), 605-616.
Veale, D. Rating scales for BDD (free to use with citation): veale.co.uk/scales.